FNY Investment Advisers’s OS Therapies Inc OSTX Stock Holding History

FNY Investment Advisers’s Portfolio OSTX Stock Details OSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100	Closed	–	–	1146
2025 Q4	$0	Buy	+100	New	+$180	﹤0.01%	1563

Other funds holding OSTX

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HFS

Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FNY Investment Advisers's OSTX Position: Q1 2026 in Review

FNY Investment Advisers sold out of OS Therapies Inc (OSTX) in Q1 2026, closing a stake of 100 shares.

FNY Investment Advisers first reported a position in OSTX in Q4 2025 and held it in 1 quarter. The position peaked at $0 in Q4 2025. 29 funds tracked by Wall St. Rank hold OSTX as of Q1 2026.

FNY Investment Advisers reported no remaining OS Therapies Inc position as of Q1 2026 after selling out during the quarter.
FNY Investment Advisers sold 100 OS Therapies Inc shares in Q1 2026.
FNY Investment Advisers first reported a position in OS Therapies Inc in Q4 2025 and held it in 1 quarter.
FNY Investment Advisers's OS Therapies Inc position peaked at $0 in Q4 2025.
29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q1 2026.

Based on FNY Investment Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.